-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Altoida announced that the company's artificial intelligence software for predictive diagnosis of Alzheimer's disease and dementia based on 20 years of cognitive research and development has obtained the breakthrough medical device designation granted by the US FDA
Through this artificial intelligence software that assists in cognitive assessment, patients only need to complete a 10-minute, video game-like cognitive assessment on their smartphone or tablet, and the software can collect their individualized brain data
Artificial intelligence system can be based on hand movements and gait and error, pupil dilation and eye tracking, voice parameters, etc.
(The original text has been deleted)
Reference materials:
[1] Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease.